Related Experiment Video
Updated: Jun 22, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
[Design of oligonucleotide inhibitors of the human DNA-methyltransferase 1]
Abstract:
Mammalian DNA methyltransferase 1 (Dnmt1) is responsible for copying DNA methylation patterns during cell division. A number of studies demonstrate that Dnmt1 plays an important role in carcinogenesis, that causes, in particular, significant interest in searching for specific inhibitors of this enzyme. In the present study, with the purpose of design of oligonucleotide inhibitors of human Dnmt1, a number of single-, double-stranded and hairpin DNA-structures, containing canonical or modified enzyme recognition site 5'-CG were constructed on the basis of uniform 22 b sequence. It was shown, that such structural features as C:A-mismatch, phosphorothioates and hairpin are capable to incrementally increase oligonucleotide affinity to Dnmt1. The improvement of inhibitor properties were also achieved by substitution of target cytosine with 5,6-dihydro-5-azacytosine, 5-methyl-2-pyrimidinone and 6-methyl-pyrrolo-[2,3-d]-2-pyrimidinone. The concentrations of the most efficient oligonucleotides caused 50% inhibition of methylation of 1 microM conventional DNA substrate, polymer poly(dI-dC) * poly(dI-dC), were about 10(-7) M. In the equal in vitro conditions the constructed oligonucleotide inhibitors demonstrated much stronger effect compared to known inhibitors of Dnmt1, which were used as controls.
Insights
Researchers designed novel oligonucleotide inhibitors targeting DNA methyltransferase 1 (Dnmt1), crucial for cell division and implicated in cancer. These modified DNA structures show enhanced affinity and potent inhibition of Dnmt1 activity in vitro.
Area of Science:
- Molecular Biology
- Biochemistry
- Medicinal Chemistry
Background:
- DNA methyltransferase 1 (Dnmt1) is essential for maintaining DNA methylation patterns during cell division.
- Dnmt1's role in carcinogenesis has spurred interest in developing specific enzyme inhibitors.
- Targeting Dnmt1 is a promising strategy for cancer therapy.
Purpose of the Study:
- To design and synthesize novel oligonucleotide inhibitors targeting human Dnmt1.
- To investigate the structure-activity relationships of various DNA modifications on Dnmt1 inhibition.
- To evaluate the inhibitory potential of designed oligonucleotides against Dnmt1.
Main Methods:
- Construction of single-, double-stranded, and hairpin DNA structures with modified recognition sites (5'-CG).
- Incorporation of structural features like C:A-mismatch, phosphorothioate linkages, and modified bases (5,6-dihydro-5-azacytosine, etc.).
- In vitro assays to determine the inhibitory concentration (IC50) against Dnmt1 using poly(dI-dC)·poly(dI-dC) as a substrate.
Main Results:
- Oligonucleotides incorporating C:A-mismatch, phosphorothioates, and hairpin structures demonstrated increased affinity for Dnmt1.
- Substitution of cytosine with modified bases further enhanced the inhibitory properties of the oligonucleotides.
- The most effective oligonucleotide inhibitors achieved 50% inhibition at approximately 10(-7) M concentrations.
Conclusions:
- Structural modifications significantly enhance the efficacy of oligonucleotide inhibitors against Dnmt1.
- Designed oligonucleotide inhibitors exhibit superior in vitro activity compared to known Dnmt1 inhibitors.
- These findings provide a foundation for developing potent Dnmt1-targeting therapeutics.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibitors of Bacterial DNA Synthesis
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...

